Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion type Assertion NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_head.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion description "[In addition, two targets of miR-146a, namely tumor necrosis factor receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK-1), were similarly expressed between rheumatoid arthritis patients and control individuals, despite increased expression of miR-146a in patients with rheumatoid arthritis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_provenance.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion evidence source_evidence_literature NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_provenance.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion SIO_000772 18759964 NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_provenance.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion wasDerivedFrom befree-20140225 NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_provenance.
- NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_assertion wasGeneratedBy ECO_0000203 NP839955.RATWZJgf8GFjhwcDNi7m9XhtB4X4gkapIxz_VGlai-xLw130_provenance.